iSpecimen: Q1 Earnings Insights

iSpecimen (NASDAQ:ISPC) reported its Q1 earnings results on Thursday, May 4, 2023 at 07:00 AM. Here’s what investors…

iSpecimen (NASDAQ:ISPC) reported its Q1 earnings results on Thursday, May 4, 2023 at 07:00 AM.

Here’s what investors need to know about the announcement.

Earnings

iSpecimen beat estimated earnings by 15.62%, reporting an EPS of $-0.27 versus an estimate of $-0.32.

Revenue was up $431 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.13 which was followed by a 3.05% drop in the share price the next day.

Here’s a look at iSpecimen’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.37 -0.34 -0.27
EPS Actual -0.24 -0.35 -0.30 -0.27
Revenue Estimate 2.67M 2.45M 2.87M 2.55M
Revenue Actual 2.96M 2.58M 2.34M 2.52M

To track all earnings releases for iSpecimen visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Lifecore Biomedical Provides Update For Development Portfolio And Timing Of Delayed Filings; Anticipates Reporting Its FY24 Q1 Results In Late October Or Early November, Pending Completion Of Its Annual Audit

Lifecore Biomedical, Inc. ("Lifecore" or the "Company"), a fully integrated contract development and manufacturing organization ("CDMO"), today provided an update on its delayed filings. The Company anticipates reporting

LFCR